Intrinsiqs

Is Astrana Health, Inc. overvalued?

Astrana Health, Inc. (ASTH) looks undervalued — trading about 86% below its fair value.

Undervalued
Current price $31.80 Fair value $59.28
Price
$31.80
Fair value
$59.28
Current P/E
21.5
Normal P/E
40.1
Market cap
$1.58B
Dividend yield
0.0%
Return on equity
6.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ASTH's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.